Overview
Financials
Revenue history (in m)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 67 days for 2021). All were audited by a statutory auditor.
- 202515/07/2026
- 202418/07/2025
- 202315/07/2024
- 202211/07/2023
- 202120/09/2022
- 202023/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
National Health Fund (NFZ) contracts
MK Pharm has been an NFZ healthcare provider since 2024. In 2026 it is performing 10 contracts with a total value of USD 32.90k. All its contracts were worth USD 77.40k in total.
NFZ contract value by year (in k USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Other services provided in pharmacies | mazowieckie | 2 | USD 16.90k |
| Other services provided in pharmacies | warmińsko-mazurskie | 3 | USD 11.09k |
| Other services provided in pharmacies | kujawsko-pomorskie | 4 | USD 4.91k |
| Other services provided in pharmacies | śląskie | 1 | USD 0.00 |
Trademarks
MK Pharm holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2010.
| Mark | Protected until | |
|---|---|---|
| Pharma-Land | Mar 19, 2030 |
Authorized Representatives
Manner of representation
The following are authorised to make declarations of will and sign on behalf of the company: 1. In the case of a one-person management board – the President of the Management Board independently. 2. In the case of a two-person management board – each member of the management board independently or a commercial proxy independently, whereas in the case of a management board consisting of more than two persons, joint action by two members of the management board or by a member of the management board jointly with a commercial proxy is required.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Krzysztof Sławomir Kaliskiage 53 | 25 | $35,116.15 | 50% |
Marcin Sobkówage 50 | 25 | $35,116.15 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2009-11-11.
42 1600 1462 1030 5315 9000 0007
96 1240 1936 1111 0011 5446 3213- 34 2030 0045 1110 0000 0357 4040
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 6,218PLN 6,218 |
Public aid
6 public aid cases recorded, with a total value of $447,676.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 1, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $26,472$26,472 | STAROSTA POWIATU GOLUB-DOBRZYŃ | |
| May 24, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $4,819$4,819 | STAROSTA POWIATU GOLUB-DOBRZYŃ | |
| Jun 3, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $408.7K$408,745 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| APIS Farmacjasp. z o.o. | $14,614,704.02 | apisapteka.pl | ||
| Farmjugsp. z o.o. | $14,506,326.49 | farmjug.pl | ||
| MybestpharmS.A. | $10,884,130.91 | mybestpharm.pl | ||
| Fragalsp. z o.o. | $5,374,285.81 | aptekafragal.pl | ||
| Modrzewscysp. j. | $5,602,358.99 | aptekacentrum.lublin.pl | ||
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl |
FAQ
Last updated: 2026-07-17